Innate Pharma releases its total number of shares outstanding as well as its voting rights as at April 30, 2010
Innate Pharma announces its turnover for the first quarter of 2010 and updates on its cash situation
Innate Pharma announces the release of its annual report and reference document (in French)
Innate Pharma to hold its Annual General Meeting of Shareholders on May 25, 2010, in Marseilles, France
Number of shares outstanding and voting rights, as of March 31, 2010
Innate Pharma updates on it next meetings with analysts and investors
Innate Pharma reports today its consolidated financial results for the year ending December 31, 2009 and updates on its drug candidates
Innate Pharma reports operating revenue of 7.7 million euros for 2009
Number of shares and voting rights and cash situation of INNATE PHARMA as at December 31, 2009
Half-year report on INNATE PHARMA’S liquidity contract with NATIXIS SECURITIES
